- Report
- March 2024
- 194 Pages
Global
From €3283EUR$3,374USD£2,812GBP
€3648EUR$3,749USD£3,125GBP
- Report
- November 2023
- 140 Pages
Global
From €5789EUR$5,950USD£4,959GBP
- Report
- December 2023
- 200 Pages
Global
From €4865EUR$5,000USD£4,168GBP
- Report
- February 2024
- 175 Pages
Global
From €4865EUR$5,000USD£4,168GBP
- Report
- December 2023
- 120 Pages
Global
From €5789EUR$5,950USD£4,959GBP
- Report
- February 2024
- 184 Pages
Global
From €3503EUR$3,600USD£3,001GBP
- Report
- March 2024
- 30 Pages
Global
From €2676EUR$2,750USD£2,292GBP
- Report
- January 2024
- 285 Pages
Global
From €9243EUR$9,500USD£7,918GBP
- Drug Pipelines
- April 2024
- 230 Pages
Global
From €2919EUR$3,000USD£2,501GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1946EUR$2,000USD£1,667GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1459EUR$1,500USD£1,250GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1946EUR$2,000USD£1,667GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1216EUR$1,250USD£1,042GBP
- Drug Pipelines
- April 2024
- 40 Pages
Global
From €1216EUR$1,250USD£1,042GBP
- Report
- June 2023
- 159 Pages
Global
From €7297EUR$7,500USD£6,251GBP
- Report
- January 2024
Asia Pacific
From €1459EUR$1,500USD£1,250GBP
- Report
- March 2020
- 357 Pages
Global
From €4767EUR$4,899USD£4,083GBP
- Report
- June 2018
- 133 Pages
Global
From €608EUR$625USD£521GBP
€1216EUR$1,250USD£1,042GBP
- Report
- February 2021
- 120 Pages
Global
From €5789EUR$5,950USD£4,959GBP
- Report
- October 2021
- 61 Pages
Global
From €4816EUR$4,950USD£4,126GBP
The Blood Brain Barrier (BBB) is a specialized membrane that separates the brain from the rest of the body. It is composed of tightly packed cells that form a barrier to protect the brain from potentially harmful substances. The BBB is an important factor in the development of Central Nervous System (CNS) drugs, as it can limit the effectiveness of certain drugs. To overcome this, drug developers must create drugs that can cross the BBB and reach the target area in the brain. This requires a deep understanding of the BBB and its components, as well as the development of new drug delivery systems.
The BBB market is an important part of the CNS drug market, as it provides the necessary tools to develop effective drugs. Companies in this market include AbbVie, AstraZeneca, Biogen, Eli Lilly, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more